LEADER 02248cam a22003735i 4500001 99131234575806421 005 20170614181211.0 006 m o d 007 cr cn||||||||| 008 020129s2017 dcu o i00 0 eng^^ 024 7 10.1596/26707 |2doi 035 (CKB)4920000001210661 035 (The World Bank)26707 035 (US-djbf)26707 035 (EXLCZ)994920000001210661 040 DJBF |beng |cDJBF |erda 110 2 World Bank. 245 10 Drug-Resistant Infections : |bA Threat to Our Economic Future. 246 Drug-Resistant Infections 264 1 Washington, D.C. : |bThe World Bank, |c2017. 336 text |btxt |2rdacontent 337 computer |bc |2rdamedia 338 online resource |bcr |2rdacarrier 347 data file |2rda 490 1 Other papers 520 3 This report examines the economic and development consequences of antimicrobial resistance(AMR)-the capacity that disease-causing microorganisms acquire to resist the drugs we've createdto fight them. The report uses World Bank Group economic simulation tools to put a price tag onAMR's destructive impacts on the global economy from 2017 through 2050, if adequate measuresaren't taken to contain the AMR threat. The report highlights actions low- and middle-income countries and their development partners can take to counter AMR, and estimates the investment required. It shows that putting resources into AMR containment now is one of the highest-yield investments countries can make. Antimicrobials are drugs that destroy disease-causing microbes, also called pathogens, such as certain bacteria, viruses, parasites, and fungi. The most familiar and important antimicrobials are antibiotics, which treat bacterial infections. Other antimicrobials combat viral and parasitic diseases, such as AIDS and malaria. Since their use began some 70 years ago, antimicrobials have saved hundreds of millions of lives. 650 4 Disease Control & Prevention 650 4 Epidemics 650 4 Health Economics & Finance 650 4 Health Monitoring & Evaluation 650 4 Health Policy and Management 650 4 Health, Nutrition and Population 650 4 International Cooperation 830 0 Other papers 830 0 World Bank e-Library. 906 BOOK